Concepedia

J.-W. Park

JP

3

Publications

128

Citations

3

H-Index

2015

Active since

Affiliations

Samsung Medical Center(Current)

National Cancer Center

University of Ulsan

Sungkyunkwan University

Asan Medical Center

J.-W. Park is an author at Samsung Medical Center specializing in oncology, pharmacotherapy, and hepatology.

Top concepts

Publications per year

2015–2019

3

Publications

3

Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma

Yoon‐Koo Kang, Thomas Yau, J.-W. Park et al. · Annals of Oncology · 2015 · 103 citations · Full text

, , +7

Outcomes based on plasma biomarkers for the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)

Lorenza Rimassa, Robin Kate Kelley, Tim Meyer et al. · Annals of Oncology · 2019 · 14 citations · Full text

, , +9

Outcomes by prior transarterial chemoembolization (TACE) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)

Thomas Yau, Ann‐Lii Cheng, Tim Meyer et al. · Annals of Oncology · 2018 · 11 citations · Full text

Rows per page

1–3 of 3